Practices of Initiation of Vasoactive Drugs in Relation to Resuscitation Fluids in Children with Septic Shock: A

Karanvir1, Shalu Gupta2, Virendra Kumar2

  • 1Department of Pediatrics, ESIC Hospital and Medical College, Faridabad, Haryana, India.

Insights

Early initiation of vasoactive infusions after the first fluid bolus in pediatric septic shock leads to faster recovery and fewer complications. This approach reduces overall fluid volume and intensive care unit stay, improving patient outcomes.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Emergency Medicine
  • Pediatric Infectious Diseases

Background:

  • The optimal timing for initiating vasoactive medications relative to fluid resuscitation in pediatric septic shock remains unclear.
  • Septic shock management guidelines emphasize fluid resuscitation, but the precise sequence with vasoactive agents requires further investigation.
  • Understanding the impact of early versus delayed vasoactive drug initiation is crucial for improving patient outcomes.

Purpose of the Study:

  • To prospectively evaluate the clinical practices and outcomes associated with the timing of vasoactive infusion initiation in relation to fluid boluses in pediatric septic shock.
  • To compare different initiation strategies: after the first (N1), second (N2), or third (N3) fluid bolus.
  • To assess secondary outcomes including time to hemodynamic stability, fluid requirements, complications, and mortality.

Main Methods:

  • A prospective observational study enrolled 100 children (1 month to 18 years) diagnosed with septic shock.
  • Patients were categorized into three groups based on when vasoactive infusions were started relative to 20 mL/kg fluid boluses (N1, N2, N3).
  • Outcomes measured included time to hemodynamic stability, fluid volume, 24-hour complications, and mortality.

Main Results:

  • The early initiation group (N1) required significantly less fluid volume (40 mL/kg) to achieve hemodynamic stability compared to N2 and N3 (70 mL/kg) (p=0.02).
  • Hemodynamic stability was achieved significantly faster in the N1 group (115 minutes) versus N2 (196 minutes) and N3 (212 minutes) (p=0.02).
  • The N1 group also showed lower 24-hour intravenous fluid requirements (p=0.02) and fewer complications (p=0.04), with no significant difference in mortality.

Conclusions:

  • Initiating vasoactive infusions after the first fluid bolus in pediatric septic shock is associated with improved outcomes.
  • Early vasoactive drug administration leads to reduced total fluid volume, faster achievement of hemodynamic stability, and fewer complications.
  • This strategy may contribute to shorter intensive care unit stays and better overall management of pediatric septic shock.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
113
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
36
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
82
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
27
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
23
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
68